Asciminib in HER2+ Breast Cancer Brain Metastases

Clinical trial NCT07136428 · RECRUITING

Trial details

NCT number: NCT07136428
Sponsor: Duke University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HER2+ Metastatic Breast Cancer

Start date: 2026-07-07
Primary completion: 2030-11-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.